Moderator: Melissa McCart, PharmD, MS – AmerisourceBergen, Xcenda
3:00 PM – 4:00 PM
General Session and Keynote Speaker
3:00 PM – 4:00 PM
General Session and Keynote Speaker
Keynote Speaker: Freda C. Lewis-Hall, MD, DFAPA, MFPM – Pfizer, Inc.
General Session
Freda C. Lewis-Hall, MD, DFAPA, MFPM – Pfizer, Inc. ### 1219691###Keynote Speaker###Former Chief Medical Officer, Chief Patient Officer and Executive Vice President at Pfizer, Inc.###Pfizer, Inc.###
Keynote Speaker: Freda C. Lewis-Hall, MD, DFAPA, MFPM – Pfizer, Inc.
4:30 PM – 5:30 PM
10 Ways to Have a Better Conversation
4:30 PM – 5:30 PM
(EDU-F4) 10 Ways to Have a Better Conversation
Keynote Speaker: Celeste Headlee
Focus on Managed Care Pharmacy
Celeste Headlee ### 1304036###Keynote Speaker###Journalist and Best Selling Author######
Keynote Speaker: Celeste Headlee
4:30 PM – 5:30 PM
Expanding Collaboration between Health-System Pharmacists and Health Plan Pharmacists in a Value-Based Contract
4:30 PM – 5:30 PM
(EDU-B4) Expanding Collaboration between Health-System Pharmacists and Health Plan Pharmacists in a Value-Based Contract
Faculty: Joseph A. Albright, PharmD – Blue Cross Blue Shield of North Carolina
Faculty: Brenden O'Hara, RPh, BCACP – Blue Cross Blue Shield of North Carolina
Business Trends Defining the Future of Managed Care Pharmacy
Joseph A. Albright, PharmD – Blue Cross Blue Shield of North Carolina ### 1055944###Faculty###Manager Clinical Pharmacy Programs###Blue Cross Blue Shield of North Carolina###
Faculty: Joseph A. Albright, PharmD – Blue Cross Blue Shield of North Carolina
@@@ Brenden O'Hara, RPh, BCACP – Blue Cross Blue Shield of North Carolina ### 857864###Faculty###Clinical Pharmacist, Provider Engagement Initiatives###Blue Cross Blue Shield of North Carolina###
Faculty: Brenden O'Hara, RPh, BCACP – Blue Cross Blue Shield of North Carolina
4:30 PM – 5:30 PM
Implementation of Harm Reduction Strategies in High-Risk Opioid-Benzodiazepine Regimens
4:30 PM – 5:30 PM
(EDU-L4) Implementation of Harm Reduction Strategies in High-Risk Opioid-Benzodiazepine Regimens
Faculty: Michael R. Jones, PharmD – University of Massachusetts Medical School - Commonwealth Medicine, Clinical Pharmacy Services
Faculty: Kimberly Lenz, PharmD – Commonwealth Medicine University of Massachusetts Medical School - Shrewsbury, MA
Legislative and Regulatory Trends
Michael R. Jones, PharmD – University of Massachusetts Medical School - Commonwealth Medicine, Clinical Pharmacy Services ### 1215083###Faculty###Clinical Consultant Pharmacist ###University of Massachusetts Medical School - Commonwealth Medicine, Clinical Pharmacy Services###
Faculty: Michael R. Jones, PharmD – University of Massachusetts Medical School - Commonwealth Medicine, Clinical Pharmacy Services
@@@ Kimberly Lenz, PharmD – Commonwealth Medicine University of Massachusetts Medical School - Shrewsbury, MA ### 306862###Faculty###Clinical Pharmacy Manager###Commonwealth Medicine University of Massachusetts Medical School - Shrewsbury, MA###
Faculty: Kimberly Lenz, PharmD – Commonwealth Medicine University of Massachusetts Medical School - Shrewsbury, MA